Literature DB >> 21161026

Multiple progressive focal nodular hyperplasia lesions of liver in a patient with hemosiderosis.

Arda Kayhan1, Nanda Venu, Hatice Lakadamyalı, Donald Jensen, Aytekin Oto.   

Abstract

Focal nodular hyperplasia (FNH) is the second most common benign lesion of the liver. It is a solitary lesion and usually does not enlarge. We present the magnetic resonance imaging findings of multiple progressive FNH lesions in a patient with hemosiderosis using Gadolinium-EOB-DTPA (Eovist) as a hepatobiliary contrast agent. The possible mechanisms underlying the occurrence and progression of FNH lesions and the potential value of Eovist in characterizing the lesions were discussed.

Entities:  

Keywords:  Focal nodular hyperplasia; Gadolinium-EOB-DTPA; Hemosiderosis; Magnetic resonance imaging

Year:  2010        PMID: 21161026      PMCID: PMC2999011          DOI: 10.4329/wjr.v2.i10.405

Source DB:  PubMed          Journal:  World J Radiol        ISSN: 1949-8470


  22 in total

1.  Progressive focal nodular hyperplasia of the liver in a patient with genetic hemochromatosis--growth promotion by iron overload?

Authors:  T Höhler; A W Lohse; P Schirmacher
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

2.  Multiple focal nodular hyperplasia of the liver associated with vascular malformations of various organs and neoplasia of the brain: a new syndrome.

Authors:  I R Wanless; S Albrecht; J Bilbao; J V Frei; E J Heathcote; E A Roberts; D Chiasson
Journal:  Mod Pathol       Date:  1989-09       Impact factor: 7.842

3.  A case of progressive multiple focal nodular hyperplasia with alteration of imaging studies.

Authors:  K Kaji; S Kaneko; E Matsushita; K Kobayashi; O Matsui; Y Nakanuma
Journal:  Am J Gastroenterol       Date:  1998-12       Impact factor: 10.864

4.  Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms.

Authors:  B N Nguyen; J F Fléjou; B Terris; J Belghiti; C Degott
Journal:  Am J Surg Pathol       Date:  1999-12       Impact factor: 6.394

5.  Assessment of sequential enhancement patterns of focal nodular hyperplasia and hepatocellular carcinoma on mangafodipir trisodium enhanced MR imaging.

Authors:  Dagmar Högemann Savellano; Herbert Köstler; Stefan Baus; Meike Mössinger; Klaus Friedrich Gratz; Arved Weimann; Michael Galanski
Journal:  Invest Radiol       Date:  2004-05       Impact factor: 6.016

6.  Progressive type of focal nodular hyperplasia characterized by multiple tumors and recurrence.

Authors:  D C Sadowski; S S Lee; I R Wanless; J K Kelly; E J Heathcote
Journal:  Hepatology       Date:  1995-04       Impact factor: 17.425

7.  Enhanced magnetic resonance imaging for tissue characterization of liver abnormalities with hepatobiliary contrast agents: an overview of preclinical animal experiments.

Authors:  Y Ni; G Marchal
Journal:  Top Magn Reson Imaging       Date:  1998-06

8.  Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial.

Authors:  Christoph J Zech; Luigi Grazioli; Josy Breuer; Maximilian F Reiser; Stefan O Schoenberg
Journal:  Invest Radiol       Date:  2008-07       Impact factor: 6.016

Review 9.  Currently used non-specific extracellular MR contrast media.

Authors:  M F Bellin; M Vasile; S Morel-Precetti
Journal:  Eur Radiol       Date:  2003-06-19       Impact factor: 5.315

10.  Prolonged positive contrast enhancement with Gd-EOB-DTPA in experimental liver tumors: potential value in tissue characterization.

Authors:  Y Ni; G Marchal; J Yu; A Mühler; G Lukito; A L Baert
Journal:  J Magn Reson Imaging       Date:  1994 May-Jun       Impact factor: 4.813

View more
  2 in total

1.  Focal nodular hyperplasia in a 14-year-old child: A case report.

Authors:  Farzan Vahedifard; Masoud Mortezazadeh; Abbas Mofidi; Mehdi Kashani; Alireza Sharifi Rayeni
Journal:  Caspian J Intern Med       Date:  2021

2.  Comparative histomorphological review of rat and human hepatocellular proliferative lesions.

Authors:  Bob Thoolen; Fiebo J W Ten Kate; Paul J van Diest; David E Malarkey; Susan A Elmore; Robert R Maronpot
Journal:  J Toxicol Pathol       Date:  2012-10-01       Impact factor: 1.628

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.